Biosimilar biological drugs in the treatment of inflammatory bowel diseases

Biosimilar biological drugs in the treatment of inflammatory bowel diseases

Within the last 20 years, tumour necrosis factor inhibitors have been proven to be effective in achieving and maintaining clinical and endoscopic remission in patients with Crohn’s disease and ulcerative colitis. Since 2013, when infliximab originator lost its patent protection, patients with inflam...

Full description

Saved in:

Bibliographic Details
Main Authors:	Magdalena Kaniewska, Piotr Eder, Anita Gąsiorowska, Maciej Gonciarz, Jarosław Kierkuś, Ewa Małecka-Panas, Grażyna Rydzewska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2019-12-01
Series:	Gastroenterology Review
Subjects:	biosimilar drugs crohn’s disease reference biologics inflammatory bowel disease ulcerative colitis
Online Access:	https://www.termedia.pl/Biosimilar-biological-drugs-in-the-treatment-of-inflammatory-bowel-diseases,41,38709,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis
by: Magdalena Kaniewska, et al.
Published: (2017-09-01)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
by: Magdalena Kaniewska, et al.
Published: (2020-11-01)

Leukocytapheresis in patients with inflammatory bowel diseases
by: Małgorzata Woźniak, et al.
Published: (2021-06-01)

The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
by: Małgorzata Woźniak, et al.
Published: (2019-03-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Inflammatory bowel disease – one entity with many molecular faces
by: Sylwia Szymańska, et al.
Published: (2019-12-01)

The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
by: Paulina Jakubczyk, et al.
Published: (2025-01-01)

Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Modern Approaches in the Morphological Diagnosis of Inflammatory Bowel Diseases
by: A. S. Tertychnyy, et al.
Published: (2022-08-01)

Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2015-05-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
by: Cheng Guo, et al.
Published: (2025-01-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
by: Edyta M. Tulewicz-Marti, et al.
Published: (2021-03-01)

Ulcerative colitis: STRIDE-ing beyond symptoms with new standards
by: Shu Wen Tay, et al.
Published: (2024-02-01)

Up-to-date overview of imaging techniques in the diagnosis and management of inflammatory bowel diseases
by: Katarzyna B. Biernacka, et al.
Published: (2019-03-01)

Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey
by: Ailsa Hart, et al.
Published: (2024-12-01)

Diagnosis and management of de novo inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series
by: Willie Mohammed Johnson, et al.
Published: (2025-01-01)

Features of development and progression of colorectal cancer on a background of ulcerative colitis
by: I. L. Khalif, et al.
Published: (2012-02-01)

Course of COVID-19 in Patients with Inflammatory Bowel Disease: Regional Experience
by: L. M. Kupkenova, et al.
Published: (2023-02-01)

Study of Fecalibacteria prausntzii in Egyptian patients with inflammatory bowel disease
by: Khaled Abd El Atty, et al.
Published: (2024-05-01)

Investigating the Activity Status of Inflammatory Bowel Disease and its Related Factors: A Study Protocol
by: Mehrnaz Asgharnezhad, et al.
Published: (2025-01-01)

Mendelian randomization analysis reveals genetic evidence for a causal link between inflammatory bowel disease and uterine cervical neoplasms
by: Chunge Cao, et al.
Published: (2025-01-01)

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01)

Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease
by: Renata d’Inca, et al.
Published: (2025-01-01)

Prevalence and predictors of small intestinal bacterial overgrowth in inflammatory bowel disease: a meta-analysis
by: Xin Feng, et al.
Published: (2025-01-01)

Inflammatory bowel disease increases the risk of pancreatitis: a two-sample bidirectional Mendelian randomization analysis
by: Li-Hui Fang, et al.
Published: (2025-01-01)

Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
by: Ronaldo Paolo Panganiban, et al.
Published: (2025-01-01)

Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
by: A. I. Akinshina, et al.
Published: (2019-05-01)

Examination of non-conventional dysplasias adjacent to colorectal adenocarcinoma in patients with IBD
by: Szintia Almási, et al.
Published: (2025-01-01)

The current standard of care of inflammatory bowel disease
by: J Wright
Published: (2024-03-01)

The Role of Vitamin D in the Pathomechanism of Inflammatory Bowel Disease (IBD) and its Therapeutic Implications - a literature review
by: Wiktoria Maria Tomaszewska, et al.
Published: (2025-01-01)

Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease
by: Jill O’Sullivan, et al.
Published: (2025-12-01)

The importance of cognitive flexibility and flexibility in coping with stress for the quality of life in inflammatory bowel disease patients during biological therapy. A preliminary report
by: Agata Rudnik, et al.
Published: (2019-01-01)

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01)

The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease
by: P. Rutgeerts
Published: (1998-01-01)

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

Using Dose-Effect Relationship for Optimising Systemic Corticosteroid Dosage in Treatment of Inflammatory Bowel Diseases
by: O. P. Alekseeva, et al.
Published: (2020-12-01)